QUOTED. Phil Brown.
Executive Summary
The Medicines and Medical Devices Act presses the UK to create regulations that make the market attractive for business. But striking the right balance in creating the new agency is crucial, said Phil Brown, director of regulation and compliance for the Association of British HealthTech Industries.
“The UK’s [technical requirements] should be at least the same as those of the EU, the US or other major world markets. There should be no place for a UK ‘light touch’ in this respect.” – Phil Brown, director of regulation and compliance, ABHI
- Find out more: If You Build It, Will They Come? Vital That UK MHRA Creates Right Environment For Medtechs
Click here for a free trial of Medtech Insight